CRON
Price
$2.54
Change
+$0.04 (+1.59%)
Updated
Oct 13, 03:38 PM (EDT)
Capitalization
961.45M
23 days until earnings call
LFCR
Price
$6.64
Change
+$0.14 (+2.15%)
Updated
Oct 13, 03:51 PM (EDT)
Capitalization
243.53M
Earnings call today
Interact to see
Advertisement

CRON vs LFCR

Header iconCRON vs LFCR Comparison
Open Charts CRON vs LFCRBanner chart's image
Cronos Group
Price$2.54
Change+$0.04 (+1.59%)
Volume$100
Capitalization961.45M
Lifecore Biomedical
Price$6.64
Change+$0.14 (+2.15%)
Volume$100
Capitalization243.53M
CRON vs LFCR Comparison Chart in %
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRON vs. LFCR commentary
Oct 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a StrongBuy and LFCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 13, 2025
Stock price -- (CRON: $2.51 vs. LFCR: $6.50)
Brand notoriety: CRON and LFCR are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRON: 63% vs. LFCR: 103%
Market capitalization -- CRON: $961.45M vs. LFCR: $243.53M
CRON [@Pharmaceuticals: Generic] is valued at $961.45M. LFCR’s [@Pharmaceuticals: Generic] market capitalization is $243.53M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 1 FA rating(s) are green whileLFCR’s FA Score has 1 green FA rating(s).

  • CRON’s FA Score: 1 green, 4 red.
  • LFCR’s FA Score: 1 green, 4 red.
According to our system of comparison, CRON is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 3 TA indicator(s) are bullish while LFCR’s TA Score has 3 bullish TA indicator(s).

  • CRON’s TA Score: 3 bullish, 6 bearish.
  • LFCR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both CRON and LFCR are a bad buy in the short-term.

Price Growth

CRON (@Pharmaceuticals: Generic) experienced а -2.71% price change this week, while LFCR (@Pharmaceuticals: Generic) price change was -6.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.86%. For the same industry, the average monthly price growth was +2.42%, and the average quarterly price growth was +55.76%.

Reported Earning Dates

CRON is expected to report earnings on Nov 05, 2025.

LFCR is expected to report earnings on Oct 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.86% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($961M) has a higher market cap than LFCR($244M). LFCR (51.23) and CRON (50.20) have similar P/E ratio . CRON YTD gains are higher at: 24.257 vs. LFCR (-12.517). LFCR has higher annual earnings (EBITDA): -8.81M vs. CRON (-25.58M). CRON has more cash in the bank: 834M vs. LFCR (8.27M). CRON has less debt than LFCR: CRON (2.01M) vs LFCR (131M). CRON (130M) and LFCR (129M) have equivalent revenues.
CRONLFCRCRON / LFCR
Capitalization961M244M394%
EBITDA-25.58M-8.81M290%
Gain YTD24.257-12.517-194%
P/E Ratio50.2051.2398%
Revenue130M129M101%
Total Cash834M8.27M10,091%
Total Debt2.01M131M2%
FUNDAMENTALS RATINGS
CRON vs LFCR: Fundamental Ratings
CRON
LFCR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
91100
PRICE GROWTH RATING
1..100
4558
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
36n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (67) in the Pharmaceuticals Other industry is in the same range as LFCR (99) in the Industrial Specialties industry. This means that CRON’s stock grew similarly to LFCR’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that CRON’s stock grew similarly to LFCR’s over the last 12 months.

CRON's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that CRON’s stock grew similarly to LFCR’s over the last 12 months.

CRON's Price Growth Rating (45) in the Pharmaceuticals Other industry is in the same range as LFCR (58) in the Industrial Specialties industry. This means that CRON’s stock grew similarly to LFCR’s over the last 12 months.

CRON's P/E Growth Rating (6) in the Pharmaceuticals Other industry is in the same range as LFCR (6) in the Industrial Specialties industry. This means that CRON’s stock grew similarly to LFCR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONLFCR
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
74%
Advances
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 14 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
82%
Bearish Trend 4 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALPKF0.58N/A
N/A
Alpek SAB DE CV
CDOAF5.50N/A
N/A
CDON AB
ADDDF217.70-4.29
-1.93%
adidas AG
SCND0.70-0.03
-4.11%
Scientific Industries, Inc.
ONEXF83.15-3.67
-4.23%
Onex Corporation

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-7.38%
SNDL - CRON
73%
Closely correlated
-10.48%
OGI - CRON
60%
Loosely correlated
-5.45%
TLRY - CRON
60%
Loosely correlated
-18.10%
CGC - CRON
57%
Loosely correlated
-16.97%
ACB - CRON
54%
Loosely correlated
-13.68%
More

LFCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-1.96%
NBIX - LFCR
36%
Loosely correlated
-1.33%
SHPH - LFCR
31%
Poorly correlated
-13.87%
AMRX - LFCR
30%
Poorly correlated
-3.11%
ALKS - LFCR
29%
Poorly correlated
-0.54%
PBH - LFCR
28%
Poorly correlated
-3.62%
More